Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrillation

NCT04694092 is registered in ClinicalTrials.gov with Institute for Clinical and Experimental Medicine as lead sponsor.

NCT NCT04694092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04694092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrillation
Lead sponsor
Institute for Clinical and Experimental Medicine
Phase
Not applicable
Overall status
Unknown status
Start date
November 5, 2020
Completion date
December 31, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure, atrial fibrillation, atrial fibrillation rapid, left ventricular dysfunction